- Q4 2023 Intelgenx Technologies Corp Earnings Call TranscriptMar 21, 2024€0.13Earnings
- Q3 2023 Intelgenx Technologies Corp Earnings Call TranscriptNov 09, 2023€0.117 (-7.87%)Earnings
- Q2 2023 Intelgenx Technologies Corp Earnings Call TranscriptAug 14, 2023€0.152 (+11.76%)Earnings
- Q1 2023 Intelgenx Technologies Corp Earnings Call TranscriptMay 11, 2023€0.114Earnings
- Q4 2022 Intelgenx Technologies Corp Earnings Call TranscriptMar 29, 2023€0.148 (-2.31%)Earnings
- Q3 2022 Intelgenx Technologies Corp Earnings Call TranscriptNov 11, 2022€0.138 (-7.07%)Earnings
- Q2 2022 Intelgenx Technologies Corp Earnings Call TranscriptAug 11, 2022€0.1855 (-4.38%)Earnings
- Q1 2022 Intelgenx Technologies Corp Earnings Call TranscriptMay 12, 2022€0.257 (+9.36%)Earnings
- Intelgenx Technologies Corp at Bloom Burton & Co. Healthcare Investor Conference TranscriptMay 03, 2022
- Q4 2021 Intelgenx Technologies Corp Earnings Call TranscriptMar 24, 2022€0.26 (-0.76%)Earnings
- Q3 2021 Intelgenx Technologies Corp Earnings Call TranscriptNov 11, 2021€0.487 (+3.40%)Earnings
- Q2 2021 Intelgenx Technologies Corp Earnings Call TranscriptAug 04, 2021€0.396 (+3.94%)Earnings
- Q1 2021 Intelgenx Technologies Corp Earnings Call TranscriptMay 13, 2021€0.481 (+2.34%)Earnings
- Q4 2020 Intelgenx Technologies Corp Earnings Call TranscriptMar 25, 2021€0.32 (-3.61%)Earnings
- Q3 2020 Intelgenx Technologies Corp Earnings Call TranscriptNov 12, 2020€0.131 (-5.35%)Earnings
- Q2 2020 Intelgenx Technologies Corp Earnings Call TranscriptAug 13, 2020€0.132 (-11.05%)Earnings
- Q1 2020 Intelgenx Technologies Corp Earnings Call TranscriptMay 14, 2020€0.1934 (+10.51%)Earnings
Q3 2022 Intelgenx Technologies Corp Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the IntelGenx third-quarter 2022 financial results call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Stephen Kilmer, Investor Relations. Sir, the floor is yours.
Thank you. Good morning, everyone, and thank you for joining us on today's call. With me on the line are Dr. Horst Zerbe, IntelGenx's CEO; Andre Godin, our President and CFO; Dr. Dana Matzen, the Company's Vice President of Business and Corporate Development; Dr. Frank Pietrantonio, our Director of Clinical Research; and Tommy Kenny, our VP, Legal Affairs and Intellectual Property, and General Counsel.
Before we begin, I would like to remind you that all amounts mentioned today are in US dollars unless otherwise indicated. And today's call may contain forward-looking information that represents our expectations as of to date and accordingly are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)